Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2013

Open Access 01-11-2013 | Meeting abstract

P02-008 - Dramatic response to canakinumab in MKD

Authors: B Makay, E Ünsal

Published in: Pediatric Rheumatology | Special Issue 1/2013

Login to get access

Excerpt

Mevalonate kinase deficiency-associated periodic fever syndrome (MKD) is a systemic autoinflammatory disease caused by mutations in the mevalonate kinase gene (MVK), previously named "hyper-IgD syndrome" due to its characteristic increase in serum IgD level. The patients suffer recurrent fever attacks every 2-8 weeks beginning from infancy, often precipitated by immunizations, infections or emotional stress. Fever lasts 2-7 days and can be accompanied by malaise, headache, diarrhea, abdominal pain, vomiting, skin rashes, arthralgia, arthritis, tender lymphadenopathy and hepatosplenomegaly. …
Metadata
Title
P02-008 - Dramatic response to canakinumab in MKD
Authors
B Makay
E Ünsal
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A115

Other articles of this Special Issue 1/2013

Pediatric Rheumatology 1/2013 Go to the issue

Meeting abstract

PW01-024 – Phenotypic analysis of a MEFV negative FMF cohort

Meeting abstract

P01-042 – Joint involvement in Armenian children with FMF

Meeting abstract

PW03-020 – A decade of ANTI-IL-1 therpay for CAPS in the UK

Meeting abstract

OR5-001 – Characterization of tonsil infiltration in PFAPA

Meeting abstract

PW01-014 – MEFV methylation analysis in FMF and JRA diseases

Meeting abstract

PW01-012 – Canakinumab in patients with FMF